WEKO3
アイテム
{"_buckets": {"deposit": "833c8a50-3600-4d00-aaff-cbd4c977c46d"}, "_deposit": {"created_by": 1, "id": "79070", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "79070"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00079070", "sets": ["1"]}, "author_link": ["1001358", "1001375", "1001357", "1001352", "1001365", "1001359", "1001370", "1001362", "1001372", "1001350", "1001351", "1001366", "1001367", "1001353", "1001360", "1001355", "1001349", "1001376", "1001374", "1001373", "1001364", "1001361", "1001354", "1001368", "1001363", "1001369", "1001356", "1001371"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2020-02", "bibliographicIssueDateType": "Issued"}, "bibliographicPageStart": "609", "bibliographicVolumeNumber": "11", "bibliographic_titles": [{"bibliographic_title": "Nature Communications"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Tumor-associated macrophages affect tumor progression and resistance to immune checkpoint therapy. Here, we identify the chemokine signal regulator FROUNT as a target to control tumor-associated macrophages. The low level FROUNT expression in patients with cancer correlates with better clinical outcomes. Frount-deficiency markedly reduces tumor progression and decreases macrophage tumor-promoting activity. FROUNT is highly expressed in macrophages, and its myeloid-specific deletion impairs tumor growth. Further, the anti-alcoholism drug disulfiram (DSF) acts as a potent inhibitor of FROUNT. DSF interferes with FROUNT-chemokine receptor interactions via direct binding to a specific site of the chemokine receptor-binding domain of FROUNT, leading to inhibition of macrophage responses. DSF monotherapy reduces tumor progression and decreases macrophage tumor-promoting activity, as seen in the case of Frount-deficiency. Moreover, co-treatment with DSF and an immune checkpoint antibody synergistically inhibits tumor growth. Thus, inhibition of FROUNT by DSF represents a promising strategy for macrophage-targeted cancer therapy.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "SPRINGER NATURE"}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1038/s41467-020-14338-5", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.nature.com/articles/s41467-020-14338-5", "subitem_relation_type_select": "URI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "2041-1723", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Terashima, Yuya"}], "nameIdentifiers": [{"nameIdentifier": "1001349", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Toda, Etsuko"}], "nameIdentifiers": [{"nameIdentifier": "1001350", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Itakura, Meiji"}], "nameIdentifiers": [{"nameIdentifier": "1001351", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Otsuji, Mikiya"}], "nameIdentifiers": [{"nameIdentifier": "1001352", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "H.W. Shand, Francis"}], "nameIdentifiers": [{"nameIdentifier": "1001353", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okumura, Kazuhiro"}], "nameIdentifiers": [{"nameIdentifier": "1001354", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoshinaga, Sosuke"}], "nameIdentifiers": [{"nameIdentifier": "1001355", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Komohara, Yoshihiro"}], "nameIdentifiers": [{"nameIdentifier": "1001356", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takeda, Mitsuhiro"}], "nameIdentifiers": [{"nameIdentifier": "1001357", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kokubo, Kana"}], "nameIdentifiers": [{"nameIdentifier": "1001358", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Meing-Chen, Chen"}], "nameIdentifiers": [{"nameIdentifier": "1001359", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yokoi, Sana"}], "nameIdentifiers": [{"nameIdentifier": "1001360", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Rokutan, Hirofumi"}], "nameIdentifiers": [{"nameIdentifier": "1001361", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kofuku, Yutaka"}], "nameIdentifiers": [{"nameIdentifier": "1001362", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohnishi, Koji"}], "nameIdentifiers": [{"nameIdentifier": "1001363", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohira, Miki"}], "nameIdentifiers": [{"nameIdentifier": "1001364", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iizasa, Toshihiko"}], "nameIdentifiers": [{"nameIdentifier": "1001365", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakano, Hirofumi"}], "nameIdentifiers": [{"nameIdentifier": "1001366", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okabe, Takayoshi"}], "nameIdentifiers": [{"nameIdentifier": "1001367", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kojima, Hirotatsu"}], "nameIdentifiers": [{"nameIdentifier": "1001368", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimizu, Akira"}], "nameIdentifiers": [{"nameIdentifier": "1001369", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kanegasaki, Shiro"}], "nameIdentifiers": [{"nameIdentifier": "1001370", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ming-Rong, Zhang"}], "nameIdentifiers": [{"nameIdentifier": "1001371", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shimada, Ichio"}], "nameIdentifiers": [{"nameIdentifier": "1001372", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nagase, Hiroki"}], "nameIdentifiers": [{"nameIdentifier": "1001373", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Terasawa, Hiroaki"}], "nameIdentifiers": [{"nameIdentifier": "1001374", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mastushima, Kouji"}], "nameIdentifiers": [{"nameIdentifier": "1001375", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Zhang, Ming-Rong", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1001376", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/79070", "pubdate": {"attribute_name": "公開日", "attribute_value": "2020-02-26"}, "publish_date": "2020-02-26", "publish_status": "0", "recid": "79070", "relation": {}, "relation_version_is_last": true, "title": ["Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties"], "weko_shared_id": -1}
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties
https://repo.qst.go.jp/records/79070
https://repo.qst.go.jp/records/790703689885f-f7e1-4a14-a623-3f587b9703ca
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2020-02-26 | |||||
タイトル | ||||||
タイトル | Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Terashima, Yuya
× Terashima, Yuya× Toda, Etsuko× Itakura, Meiji× Otsuji, Mikiya× H.W. Shand, Francis× Okumura, Kazuhiro× Yoshinaga, Sosuke× Komohara, Yoshihiro× Takeda, Mitsuhiro× Kokubo, Kana× Meing-Chen, Chen× Yokoi, Sana× Rokutan, Hirofumi× Kofuku, Yutaka× Ohnishi, Koji× Ohira, Miki× Iizasa, Toshihiko× Nakano, Hirofumi× Okabe, Takayoshi× Kojima, Hirotatsu× Shimizu, Akira× Kanegasaki, Shiro× Ming-Rong, Zhang× Shimada, Ichio× Nagase, Hiroki× Terasawa, Hiroaki× Mastushima, Kouji× Zhang, Ming-Rong |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Tumor-associated macrophages affect tumor progression and resistance to immune checkpoint therapy. Here, we identify the chemokine signal regulator FROUNT as a target to control tumor-associated macrophages. The low level FROUNT expression in patients with cancer correlates with better clinical outcomes. Frount-deficiency markedly reduces tumor progression and decreases macrophage tumor-promoting activity. FROUNT is highly expressed in macrophages, and its myeloid-specific deletion impairs tumor growth. Further, the anti-alcoholism drug disulfiram (DSF) acts as a potent inhibitor of FROUNT. DSF interferes with FROUNT-chemokine receptor interactions via direct binding to a specific site of the chemokine receptor-binding domain of FROUNT, leading to inhibition of macrophage responses. DSF monotherapy reduces tumor progression and decreases macrophage tumor-promoting activity, as seen in the case of Frount-deficiency. Moreover, co-treatment with DSF and an immune checkpoint antibody synergistically inhibits tumor growth. Thus, inhibition of FROUNT by DSF represents a promising strategy for macrophage-targeted cancer therapy. | |||||
書誌情報 |
Nature Communications 巻 11, p. 609, 発行日 2020-02 |
|||||
出版者 | ||||||
出版者 | SPRINGER NATURE | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 2041-1723 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1038/s41467-020-14338-5 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.nature.com/articles/s41467-020-14338-5 |